PolyPid Ltd.

NasdaqCM PYPD

PolyPid Ltd. Goodwill for the year ending December 31, 2023

PolyPid Ltd. Goodwill is NA for the year ending December 31, 2023. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

PolyPid Ltd. Goodwill for the year ending December 31, 2022 was USD 0.00.
PolyPid Ltd. Goodwill for the year ending December 31, 2019 was USD 0.00.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

NasdaqCM: PYPD

PolyPid Ltd.

CEO	Ms. Dikla Czaczkes Akselbrad
IPO Date	June 26, 2020
Location	Israel
Headquarters	18 Hasivim Street
Employees	59
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Medical Instruments Pharmaceuticals Plastics Vaccines

Description

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Key trends

Past 5 years